Argan, Inc. AGX
364.29
3.23
0.89%
as of 25 Sep
- Market cap
- $5.1B
- P/E
- 28.3×
Follow AGX
Growth Flags
show if company had growth for consecutive years
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
44.36 | 57.61 | 35.65 | 35.00 |
+8 more quarters Free account |
P/S ratio |
6.73 | 8.98 | 5.19 | 4.63 | |
P/FCF ratio |
14.66 | 19.21 | 11.93 | 14.97 | |
P/Operating CF |
82.52 | 82.48 | 28.43 | 24.55 | |
P/B ratio |
15.79 | 19.75 | 10.60 | 10.09 | |
Price to Tangible BV |
17.02 | 21.06 | 11.32 | 10.85 | |
EV/Sales |
5.87 | 8.04 | 4.24 | 3.83 | |
EV/EBITDA |
37.75 | 53.09 | 29.31 | 28.84 | |
EV/Operating CF |
12.56 | 17.00 | 9.66 | 12.22 | |
EV/FCF |
12.78 | 17.21 | 9.75 | 12.40 | |
Quick Ratio |
1.38 | 1.39 | 1.45 | 1.45 | |
Current Ratio |
1.50 | 1.53 | 1.59 | 1.61 | |
Net Debt/EBITDA |
(17.90) | (21.19) | (18.58) | (21.93) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.04 | 1.00 | 0.93 | 1.01 | |
Operating CF/Net income |
1.82 | 2.46 | 3.50 | 5.61 | |
Capex/Depreciation |
(8.15) | (4.35) | (2.41) | (1.15) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.53% | 5.40% | 6.84% | 5.70% | |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.03 | |
Share Based Compensation of Revenue |
0.63% | 0.70% | 0.97% | 0.74% | |
Graham Net Nets |
0.05 | 0.04 | 0.08 | 0.09 | |
Graham Number |
102.25 | 94.21 | 86.82 | 77.30 | |
Earnings Yield |
2.25% | 1.74% | 2.81% | 2.86% | |
Free Cash Flow Yield |
6.82% | 5.21% | 8.39% | 6.68% | |
Revenue per Share |
27.37 | 20.84 | 19.03 | 18.16 | |
Operating CF per Share |
6.91 | 8.12 | 12.51 | 12.47 | |
Capex per Share |
(0.37) | (0.17) | (0.09) | (0.04) | |
Free Cash Flow per Share |
6.54 | 7.95 | 12.43 | 12.43 | |
Cash per Share |
73.31 | 69.74 | 64.99 | 52.55 | |
Shareholders Equity per Share |
36.13 | 33.92 | 33.57 | 30.35 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
36.13 | 33.92 | 33.57 | 30.35 | |
Free Cash Flow |
91.72 | 110.95 | 171.13 | 171.91 | |
Working Capital |
440.36 | 421.42 | 421.00 | 377.31 | |
Capital Expenditures |
(5.25) | (2.43) | (1.20) | (0.58) | |
Net Current Asset Value |
424.34 | 403.18 | 408.17 | 366.01 | |
EV/EBIT |
38.21 | 53.79 | 29.73 | 29.31 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 | |
Net Profit Margin |
13.88% | 15.83% | 18.78% | 12.24% | |
Price to Operating Income |
43.85 | 60.05 | 36.37 | 35.38 | |
| Other line items | |||||
Average Receivables |
179.76 | 118.65 | 154.74 | 151.02 | |
Average Payables |
105.63 | 96.56 | 102.42 | 93.94 | |
Average Assets |
1,141.84 | 1,039.30 | 1,011.29 | 909.87 | |
Average Common Equity |
450.01 | 418.70 | 407.06 | 374.21 |
Columns are period end dates